Skip to main content
. Author manuscript; available in PMC: 2024 May 17.
Published in final edited form as: Nat Med. 2023 Feb 6;29(2):467–472. doi: 10.1038/s41591-022-02183-6

Table 3 |.

Comparison of the Mayo Clinic 2/20/20 and PETHEMA risk stratification models in 87 patients with SMM evaluated with both models

Mayo Clinic 2/20/20 model PETHEMA model
Low risk Intermediate risk High risk
Low risk 31 11 4
Intermediate risk 14 9 6
High risk 1 6 5
Overall agreement for 45 of 87 patients (52%)